Novel ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
Novel bicyclic compounds having the structural formula (I): 1
are useful in a variety of pharmaceutical applications, whether human or
veterinary, and also in cosmetics.